Literature DB >> 28012946

Impaired GABAergic inhibition in the hippocampus of Fmr1 knockout mice.

Victor Sabanov1, Sien Braat2, Laura D'Andrea3, Rob Willemsen4, Shimriet Zeidler5, Liesbeth Rooms6, Claudia Bagni7, R Frank Kooy8, Detlef Balschun9.   

Abstract

Many clinical and molecular features of the fragile X syndrome, a common form of intellectual disability and autism, can be modeled by deletion of the Fmr1 protein (Fmrp) in mice. Previous studies showed a decreased expression of several components of the GABAergic system in Fmr1 knockout mice. Here, we used this mouse model to investigate the functional consequences of Fmrp deletion on hippocampal GABAergic inhibition in the CA1-region of the hippocampus. Whole-cell patch-clamp recordings demonstrated a significantly reduced amplitude of evoked inhibitory postsynaptic currents (eIPSCs) and a decrease in the amplitude and frequency of spontaneous IPSCs. In addition, miniature IPSCs were reduced in amplitude and frequency and decayed significantly slower than mIPSCs in controls. Quantitative real-time PCR revealed a significantly lower expression of α2, β1 and δ GABAA receptor subunits in the hippocampus of the juvenile mice (P22) compared to wild-type littermates. Correspondingly, we found also at the protein level reduced amounts of α2, β1 and δ subunits in Fmr1 knockout mice. Overall, these results demonstrate that the reduction in several components of the GABAergic system is already present at young age and that this reduction results in measurable abnormalities on GABAA receptor-mediated phasic inhibition. These abnormalities might contribute to the behavioral and cognitive deficits of this fragile X mouse model.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fmr1 knockout mice; Fragile X syndrome; GABA(A) receptor subunit; Hippocampus; Inhibitory postsynaptic current

Mesh:

Substances:

Year:  2016        PMID: 28012946     DOI: 10.1016/j.neuropharm.2016.12.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  25 in total

Review 1.  Multifarious Functions of the Fragile X Mental Retardation Protein.

Authors:  Jenna K Davis; Kendal Broadie
Journal:  Trends Genet       Date:  2017-08-18       Impact factor: 11.639

2.  Decreased surface expression of the δ subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome.

Authors:  Nianhui Zhang; Zechun Peng; Xiaoping Tong; A Kerstin Lindemeyer; Yliana Cetina; Christine S Huang; Richard W Olsen; Thomas S Otis; Carolyn R Houser
Journal:  Exp Neurol       Date:  2017-08-16       Impact factor: 5.330

3.  FMRP regulates GABAA receptor channel activity to control signal integration in hippocampal granule cells.

Authors:  Pan-Yue Deng; Ajeet Kumar; Valeria Cavalli; Vitaly A Klyachko
Journal:  Cell Rep       Date:  2022-05-17       Impact factor: 9.995

4.  Spontaneous seizures in adult Fmr1 knockout mice: FVB.129P2-Pde6b+Tyrc-chFmr1tm1Cgr/J.

Authors:  Jessica L Armstrong; Tanishka S Saraf; Omkar Bhatavdekar; Clinton E Canal
Journal:  Epilepsy Res       Date:  2022-03-08       Impact factor: 2.991

Review 5.  Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

Authors:  Mrinmoyee Majumder; Roger H Johnson; Viswanathan Palanisamy
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-02       Impact factor: 8.250

6.  Enhanced postsynaptic inhibitory strength in hippocampal principal cells in high-performing aged rats.

Authors:  Trinh Tran; Michela Gallagher; Alfredo Kirkwood
Journal:  Neurobiol Aging       Date:  2018-06-12       Impact factor: 4.673

Review 7.  Reactivation of FMR1 gene expression is a promising strategy for fragile X syndrome therapy.

Authors:  Ekaterina M Shitik; Anastasia A Velmiskina; Alexander A Dolskiy; Dmitry V Yudkin
Journal:  Gene Ther       Date:  2020-03-12       Impact factor: 5.250

Review 8.  Channelopathies in fragile X syndrome.

Authors:  Pan-Yue Deng; Vitaly A Klyachko
Journal:  Nat Rev Neurosci       Date:  2021-04-07       Impact factor: 34.870

9.  Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.

Authors:  Carlo Brighi; Federico Salaris; Alessandro Soloperto; Alessandro Rosa; Silvia Di Angelantonio; Federica Cordella; Silvia Ghirga; Valeria de Turris; Maria Rosito; Pier Francesca Porceddu; Chiara D'Antoni; Angelo Reggiani
Journal:  Cell Death Dis       Date:  2021-05-15       Impact factor: 8.469

10.  Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice.

Authors:  Tanishka S Saraf; Daniel E Felsing; Jessica L Armstrong; Raymond G Booth; Clinton E Canal
Journal:  Epilepsy Res       Date:  2021-05-27       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.